Favorites Sign in
  1. Home
  2. Companies
  3. Stock Keros Therapeutics
Keros Therapeutics logo

Keros Therapeutics KROS

$ 10.66 0.45%
report update icon

Quarterly report 2026-Q2
added 08-03-2026

Country

 usaUSA

IPO year

 2020

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 37.2 M

Market Cap[1]

 $ 397 M

EBITDA (LTM)

 $ 69.1 M

P/E (LTM)

 4.837607

P/S (LTM)

 1.727783

EPS (LTM)

 2.34

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Trevi Therapeutics Trevi Therapeutics
TRVI
 		$ 11.88 0.41 % $ 1.6 B Nasdaq Global Market usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
 		- -18.25 % $ 5.04 M Nasdaq Global Market israelIsrael
Taysha Gene Therapies Taysha Gene Therapies
TSHA
 		$ 3.62 6.27 % $ 1.16 B Nasdaq Global Select Market usaUSA
Innoviva Innoviva
INVA
 		$ 20.78 0.19 % $ 1.4 B Nasdaq Global Select Market usaUSA
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
 		$ 34.56 0.08 % $ 1.66 B Nasdaq Global Select Market israelIsrael
United Therapeutics Corporation United Therapeutics Corporation
UTHR
 		$ 533.12 0.27 % $ 23.6 B Nasdaq Global Select Market,SPB usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
 		$ 0.21 0.4 % $ 9.6 M Nasdaq Capital Market israelIsrael
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
 		- 17.91 % $ 11.1 M Nasdaq Capital Market usaUSA
Vericel Corporation Vericel Corporation
VCEL
 		$ 40.13 0.33 % $ 2.02 B Nasdaq Global Select Market,SPB usaUSA
Veracyte Veracyte
VCYT
 		$ 43.12 1.16 % $ 3.39 B Nasdaq Global Market,SPB usaUSA
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
 		$ 3.5 4.72 % $ 566 M Nasdaq Global Select Market usaUSA
Vir Biotechnology Vir Biotechnology
VIR
 		$ 9.96 0.58 % $ 1.38 B Nasdaq Global Select Market,SPB usaUSA
Viking Therapeutics Viking Therapeutics
VKTX
 		$ 25.17 7.46 % $ 2.84 B Nasdaq Capital Market usaUSA
Vanda Pharmaceuticals Vanda Pharmaceuticals
VNDA
 		$ 4.04 0.24 % $ 238 M Nasdaq Global Select Market,SPB usaUSA
Genmab A/S Genmab A/S
GMAB
 		$ 37.0 0.33 % $ 2.39 B Nasdaq Global Select Market danmarkDanmark
Verrica Pharmaceuticals Verrica Pharmaceuticals
VRCA
 		$ 3.6 0.79 % $ 38.3 M Nasdaq Global Market usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
 		$ 19.03 0.92 % $ 1.94 B Nasdaq Capital Market usaUSA
Inventiva S.A. Inventiva S.A.
IVA
 		$ 2.94 8.36 % $ 176 M Nasdaq Global Market franceFrance
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
 		$ 0.46 0.02 % $ 5.09 M Nasdaq Capital Market usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Verastem Verastem
VSTM
 		$ 8.65 0.05 % $ 600 M Nasdaq Global Market usaUSA
VistaGen Therapeutics VistaGen Therapeutics
VTGN
 		$ 0.2 3.1 % $ 7.61 M Nasdaq Global Select Market usaUSA
vTv Therapeutics vTv Therapeutics
VTVT
 		$ 26.54 0.25 % $ 105 M Nasdaq Global Select Market usaUSA
Voyager Therapeutics Voyager Therapeutics
VYGR
 		$ 1.9 2.49 % $ 112 M Nasdaq Global Select Market usaUSA
Genprex Genprex
GNPX
 		$ 2.11 1.31 % $ 1.97 M Nasdaq Capital Market usaUSA
Wave Life Sciences Ltd. Wave Life Sciences Ltd.
WVE
 		$ 3.13 0.78 % $ 528 M Nasdaq Global Select Market singaporeSingapore
Agenus Agenus
AGEN
 		$ 6.04 2.77 % $ 180 M Nasdaq Capital Market usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
 		$ 1.98 0.48 % $ 3.37 M Nasdaq Capital Market usaUSA
XBiotech XBiotech
XBIT
 		$ 2.12 1.67 % $ 64.6 M Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
 		$ 33.49 1.27 % $ 2.65 B Nasdaq Global Select Market canadaCanada
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
 		$ 10.31 2.38 % $ 1.65 B Nasdaq Global Select Market usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
 		$ 2.59 0.19 % $ 110 M Nasdaq Capital Market usaUSA
Kodiak Sciences Kodiak Sciences
KOD
 		$ 85.75 0.64 % $ 4.56 B Nasdaq Global Market,SPB usaUSA
22nd Century Group 22nd Century Group
XXII
 		$ 0.34 0.98 % $ 62.6 K NYSE American usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
 		$ 121.84 0.27 % $ 14.6 B Nasdaq Global Select Market,SPB usaUSA
Arvinas Arvinas
ARVN
 		$ 6.97 1.12 % $ 494 M Nasdaq Global Select Market,SPB usaUSA
Zai Lab Limited Zai Lab Limited
ZLAB
 		$ 23.19 0.79 % $ 25.4 B Nasdaq Global Select Market chinaChina
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
 		$ 2.13 0.83 % $ 153 M Nasdaq Global Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		$ 1.6 1.78 % $ 426 M Nasdaq Global Select Market britainBritain
BridgeBio Pharma BridgeBio Pharma
BBIO
 		$ 66.39 3.37 % $ 12.7 B Nasdaq Global Select Market,SPB usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
 		$ 1.21 4.03 % $ 63.6 M Nasdaq Global Select Market usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
 		$ 37.95 0.17 % $ 2.18 B Nasdaq Global Select Market usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
 		$ 7.25 0.54 % $ 111 M Nasdaq Global Select Market australiaAustralia
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
 		$ 4.85 3.08 % $ 2.15 M Nasdaq Capital Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
MacroGenics MacroGenics
MGNX
 		$ 3.25 1.81 % $ 205 M Nasdaq Global Select Market usaUSA
iBio iBio
IBIO
 		$ 0.77 0.63 % $ 80.1 M NYSE American usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
 		$ 61.95 0.77 % $ 7.44 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.